Imel Biotherapeutics

Waltham, United States

Imel Biotherapeutics develops cell-based therapies to treat patients with mitochondrial disorders.

$15.0M raised

Nov 2021

Series A

Biotechnology Life Science Medical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Imel Biotherapeutics

How much funding has Imel Biotherapeutics raised?

Imel Biotherapeutics has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in November 2021.

Where is Imel Biotherapeutics headquartered?

Imel Biotherapeutics is headquartered in Waltham, United States.

What does Imel Biotherapeutics do?

Imel Biotherapeutics develops cell-based therapies to treat patients with mitochondrial disorders.

What stage is Imel Biotherapeutics at?

Imel Biotherapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 15, 2021.

MLA

"Imel Biotherapeutics — Funding & Investors." VCBacked, November 15, 2021, https://www.vcbacked.co/company/imel-biotherapeutics. Accessed July 2, 2026.

APA

VCBacked. (2021). Imel Biotherapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/imel-biotherapeutics

Wikipedia (cite web)

{{cite web |title=Imel Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/imel-biotherapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 15, 2021.